CAMBRIDGE, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres or the Company), a leading ...

The results showed that the SOFA scores of the drug treatment groups on the 7th day were significantly lower than those of the baseli ...

Annamycin has the potential to be safer and more effective than current prescribed anthracyclines to treat serious, ...

Apellis reported a net loss of $92.2 million for the first quarter of 2025 compared to a net loss of $66.4 million for the same period in 2024. Cash. As of March 31, 2025, Apellis had $358.4 million ...

Lyme disease treatment market was valued at USD 8,247 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period (2025-2035). Lyme Disease Treatment Market: $8.24B in 2024, ...

How to create herbal blends for seasonal allergies using nettle turmeric elder and more for natural symptom relief and immune ...

Nevertheless, a crackdown on DEI has been used to justify axing numerous studies seeking to shed light on Alzheimer’s disease ...

Announces successful completion of sub-chronic and chronic toxicology studies for INF904, supporting long-term dosing in future clinical trialsMultiple near-term catalysts anticipated with the potenti ...